BioCentury
ARTICLE | Clinical News

Bafetinib: Pilot trial started

November 22, 2010 8:00 AM UTC

CytRx began an open-label, U.S. pilot trial in 6-8 patients with recurrent primary brain cancer or recurrent brain metastases to evaluate twice-daily oral bafetinib following intracerebral microdialys...